Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Capricor Inc.
Craig M McDonald; Eduardo Marbán; Suzanne Hendrix; Nathaniel Hogan; Rachel Ruckdeschel Smith; Michelle Eagle; Richard S Finkel; Cuixia Tian; Joanne Janas; Matthew M Harmelink; Arun S Varadhachary; Michael D Taylor; Kan N Hor; Oscar H Mayer; Erik K Henricson; Pat Furlong; Deborah D Ascheim; Siegfried Rogy; Paula Williams; Linda Marbán; HOPE-2 Study Group